Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholders??? Equity

v3.21.2
Consolidated Statements of Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Previously Reported
Retroactive application of reverse recapitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Retroactive application of reverse recapitalization
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive application of reverse recapitalization
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Previously Reported
Accumulated Deficit
Accumulated Deficit
Previously Reported
Beginning balance (in shares) at Dec. 31, 2019       66,637 1 66,636              
Beginning balance at Dec. 31, 2019 $ 38,218 $ 38,218 $ 0 $ 7 $ 0 $ 7 $ 58,612 $ 58,619 $ (7) $ (218) $ (218) $ (20,183) $ (20,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (105)                 (105)      
Stock-based compensation 157           157            
Net loss (553)                     (553)  
Ending balance (in shares) at Mar. 31, 2020       66,637                  
Ending balance at Mar. 31, 2020 37,717     $ 7     58,769     (323)   (20,736)  
Beginning balance (in shares) at Dec. 31, 2019       66,637 1 66,636              
Beginning balance at Dec. 31, 2019 38,218 38,218 0 $ 7 $ 0 $ 7 58,612 58,619 (7) (218) (218) (20,183) (20,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net loss (4,402)                        
Ending balance (in shares) at Sep. 30, 2020       66,637                  
Ending balance at Sep. 30, 2020 34,187     $ 7     59,082     (317)   (24,585)  
Beginning balance (in shares) at Dec. 31, 2019       66,637 1 66,636              
Beginning balance at Dec. 31, 2019 38,218 38,218 0 $ 7 $ 0 $ 7 58,612 58,619 (7) (218) (218) (20,183) (20,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 200                        
Ending balance (in shares) at Dec. 31, 2020       66,637 1 66,636              
Ending balance at Dec. 31, 2020 34,141 34,141 0 $ 7 $ 0 $ 7 59,168 59,175 (7) (206) (206) (24,828) (24,828)
Beginning balance (in shares) at Mar. 31, 2020       66,637                  
Beginning balance at Mar. 31, 2020 37,717     $ 7     58,769     (323)   (20,736)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment (9)                 (9)      
Stock-based compensation 156           156            
Net loss (3,519)                     (3,519)  
Ending balance (in shares) at Jun. 30, 2020       66,637                  
Ending balance at Jun. 30, 2020 34,345     $ 7     58,925     (332)   (24,255)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 15                 15      
Stock-based compensation 157           157            
Net loss (330)                     (330)  
Ending balance (in shares) at Sep. 30, 2020       66,637                  
Ending balance at Sep. 30, 2020 34,187     $ 7     59,082     (317)   (24,585)  
Beginning balance (in shares) at Dec. 31, 2020       66,637 1 66,636              
Beginning balance at Dec. 31, 2020 34,141 34,141 0 $ 7 $ 0 $ 7 59,168 59,175 (7) (206) (206) (24,828) (24,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 39                 39      
Stock-based compensation 139           139            
Net loss (4,175)                     (4,175)  
Ending balance (in shares) at Mar. 31, 2021       66,637                  
Ending balance at Mar. 31, 2021 30,144     $ 7     59,307     (167)   (29,003)  
Beginning balance (in shares) at Dec. 31, 2020       66,637 1 66,636              
Beginning balance at Dec. 31, 2020 34,141 $ 34,141 $ 0 $ 7 $ 0 $ 7 59,168 $ 59,175 $ (7) (206) $ (206) (24,828) $ (24,828)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Foreign currency translation adjustment 200                        
Net loss (91,362)                        
Ending balance (in shares) at Sep. 30, 2021       90,547                  
Ending balance at Sep. 30, 2021 134,607     $ 9     251,021     (233)   (116,190)  
Beginning balance (in shares) at Mar. 31, 2021       66,637                  
Beginning balance at Mar. 31, 2021 30,144     $ 7     59,307     (167)   (29,003)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Merger and PIPE financing (in shares)       20,448                  
Merger and PIPE financing 190,399     $ 2     190,397            
Foreign currency translation adjustment (25)                 (25)      
Stock-based compensation 139           139            
Net loss (75,843)                     (75,843)  
Ending balance (in shares) at Jun. 30, 2021       87,085                  
Ending balance at Jun. 30, 2021 144,814     $ 9     249,843     (192)   (104,846)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Equity incentive bonus (in shares)       3,462                  
Equity incentive bonus (2)           (2)            
Foreign currency translation adjustment (41)                 (41)      
Stock-based compensation 1,180           1,180            
Net loss (11,344)                     (11,344)  
Ending balance (in shares) at Sep. 30, 2021       90,547                  
Ending balance at Sep. 30, 2021 $ 134,607     $ 9     $ 251,021     $ (233)   $ (116,190)